Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

IntelGenx Technologies Corp. (OTC: IGXT - News) shares closed down 11.96 percent on Wednesday with about 4.8 million shares traded. The stock was one of the most active stocks in the OTC market and ...

Intelgenx Technologies (IGXT) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on May 15, 2024 for Q1.

IntelGenx Technologies Corp. (OTC: IGXT - News) shares closed down 6.49 percent on Tuesday on about 2.2 million shares traded. The stock was one of the biggest decliners in the OTC market. IntelGenx, ...

IntelGenx (IGXT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.01 per share a year ago. These figures are ...

IntelGenx Technologies Corp. IGX IGXT reported its financial results late Thursday for the third quarter that ended September 30, 2022. Dr. Horst G. Zerbe, CEO of IntelGenx called the third quarter a ...

Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...

MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OTC: IGXT), a leading drug delivery company focused on the development and manufacturing of ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.